Physician profile
Thomas B Sullivan
NPI 1841212032
$4,509.69
in general payments reported to CMS, 2019-2025
38 companies · $641 in 2025
The $641 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,232 · 2022: $994 · 2023: $932 · 2024: $711 · 2025: $641.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,284.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,284.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $840.03 | 2021-2025 | Ozempic, Rybelsus |
| Abbvie INC. | $657.02 | 2021-2025 | |
| Lilly USA, LLC | $592.64 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $324.98 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Astellas Pharma US INC | $219.67 | 2021-2025 | Veozah |
| Astrazeneca Pharmaceuticals LP | $192.01 | 2021-2025 | Airsupra, Farxiga |
| Exact Sciences Corporation | $184.12 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Biohaven Pharmaceuticals, INC. | $122.12 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $114.84 | 2021-2022 | |
| Corcept Therapeutics | $112.81 | 2024-2025 | Korlym |
| Daiichi Sankyo INC. | $111.96 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $101.87 | 2021-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $101.46 | 2021-2025 | Xifaxan |
| Pfizer INC. | $89.82 | 2021-2023 | |
| Otsuka America Pharmaceutical, INC. | $79.67 | 2023-2024 | Rexulti, Abilify Maintena |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Sullivan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.